tyrosine kinase inhibitor - Globe Thesis

Keyword [tyrosine kinase inhibitor] Result: 41 - 60 \| Page: 3 of 10
41.	Observation On The Therapeutic Effect Of Antipruritic Skin Cream On EGFR - TKI - Related Rash
42.	An Exploratory Study On The Changes Of Serum Polypeptide And Its Clinical Significance In The Treatment Of EGFR - TKI In Patients With Advanced NSCLC
43.	Quinazoline Receptor Tyrosine Kinase Small-molecule Inhibitors
44.	Serum CEA Level Is Associated With Efficacy And Prognosis Of EGFR-TKI Treatment In Non-small Cell Lung Cancer
45.	The Effect Of Lapatinib And DPP On Cervical Adenocarcinoma Cells And Its Mechanism
46.	Design And Synthesis Of Anti-tumor Protein Tyrosine Kinase Inhibitor
47.	Design,synthesis Andanti-tumor Activities Ofaryl Urea Derivatives As Novel Tyrosine Kinase Inhibitors
48.	Quinazolines Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Synthesis Research
49.	Studies On Design, Synthesis And Bioactivity Of Anti-cancer Drugs Based On C-Met Target And Combretastatin A-4Analogues
50.	Tivozanib Reverses Multidrug Resistance Mediated By ABCB1(P-glycoprotein) And ABCG2(BCRP)
51.	Correlative Clinical And Experimental Research On The TKI-Treatment Of Advanced Renal Cell Carcinoma
52.	Luteolin Is Effective In The Non-small Cell Lung Cancer Model With L858R/T790M EGF Receptor Mutation And Eriotinib Resistance
53.	1.Basic And Clinical Reaearch Of Drug Resistant Genes For The Evaluation Of Chemotherapy Curative Effect In Lung Cancer 2.Subsequent Treatment Of EGRF Tyrosine Kinase Inhibitor Failure In Patients With Advanced Lung Adenocarcinoma
54.	A Research On Drug-resistant Mutations In HER2-positive Breast Cancer Based On Circulating Tumor DNA And CRISPR/cas9 Technique
55.	The Reversal Effect Of Afatinib On ABCB1-mediated Multidrug Resistance In Human Ovarian Cancer And Its Mechanisms
56.	Screening And Research Selective Anti-Hepatoma Drugs From The Traditional Chuang And Yao Medicine In Guangxi By Tyrosine Kinase, Angiogenesis As Antitumor Drug Targets
57.	Clinical Research Of The Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor In Maintenance Therapy Advanced Non-small Cell Lung Cancer
58.	Design,Synthesis And Anti-tumor Activities Of Aiyl Quinoline Derivatives As Novel Tyrosine Kinase Inhibitors
59.	EGFR Genomic CA-simple Sequence Repeat Polymorphism In NSCLC Patients Treated With Tyrosine Kinase Inhibitor Therapy:a Meta-analysis And Systematic Review
60.	Design, Synthesis, And Biological Evaluation Of Novel Syk Inhibitors For Application To Rheumatoid Arthritis Treatment
<<First <Prev Next> Last>> Jump to